CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Doxycycline monohydrate

Last Updated: April 27, 2012
Result type: Reports
Project Number: SR0279-000
Product Line: Reimbursement Review

Generic Name: Doxycycline monohydrate

Brand Name: Apprilon

Manufacturer: Galderma Canada Inc.

Therapeutic Area: Rosacea

Indications: Rosacea treatment

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 27, 2013

Recommendation Type: Do not list